• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西布曲明和利莫那班对经训练可区分22小时和2小时食物剥夺的大鼠的影响。

Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation.

作者信息

Jewett David C, Hahn Thomas W, Smith Travis R, Fiksdal Britta L, Wiebelhaus Jason M, Dunbar Andrew R, Filtz Catherine R, Novinska Noah L, Levine Allen S

机构信息

Department of Psychology, University of Wisconsin-Eau Claire, Eau Claire, WI, USA.

出版信息

Psychopharmacology (Berl). 2009 Apr;203(2):453-9. doi: 10.1007/s00213-008-1350-1. Epub 2008 Oct 15.

DOI:10.1007/s00213-008-1350-1
PMID:18854986
Abstract

OBJECTIVE

The objective of the study was to evaluate whether sibutramine and rimonabant, drugs that decrease food intake in human and non-human animals, affect the discriminative stimulus effects associated with acute food deprivation ("hunger").

MATERIALS AND METHODS

Rats were trained to discriminate between 22- and 2-h food deprivation in a two-lever choice procedure. After rats acquired the discrimination, subjects were food-restricted for 22 h and administered with sibutramine (0.32-10 mg/kg, p.o.) or rimonabant (0.32-10 mg/kg, s.c.) before a generalization test session.

RESULTS

Sibutramine (3.2 mg/kg) produced significant decreases in 22-h deprivation-appropriate responding, response rates (resulting in lever pressing rates similar to those following 2-h food deprivation), and food intake measured 1 h after the generalization test. A larger sibutramine dose eliminated responding and significantly reduced food intake. Rimonabant did not alter the discriminative stimulus effects of 22-h food deprivation, but rimonabant did significantly reduce both response rates and food intake.

CONCLUSION

Sibutramine appears to decrease food intake by reducing hunger sensations associated with food deprivation. In contrast, rimonabant does not alter the discrimination of acute food deprivation. The use of food-deprivation discrimination techniques may be useful in identifying the role of specific neuroactive compounds in eating stimulated by a sense of hunger and may aid in medication development for more effective treatments for obesity and other eating-related conditions.

摘要

目的

本研究的目的是评估西布曲明和利莫那班这两种能减少人类和非人类动物食物摄入量的药物,是否会影响与急性食物剥夺(“饥饿”)相关的辨别刺激效应。

材料与方法

在双杠杆选择程序中训练大鼠区分22小时和2小时的食物剥夺情况。大鼠获得辨别能力后,对其进行22小时的食物限制,并在泛化测试前给予西布曲明(0.32 - 10毫克/千克,口服)或利莫那班(0.32 - 10毫克/千克,皮下注射)。

结果

西布曲明(3.2毫克/千克)使22小时剥夺相关反应显著减少,反应率(导致杠杆按压率与2小时食物剥夺后的相似)以及泛化测试后1小时测量的食物摄入量均显著降低。更高剂量的西布曲明消除了反应并显著降低了食物摄入量。利莫那班未改变22小时食物剥夺的辨别刺激效应,但显著降低了反应率和食物摄入量。

结论

西布曲明似乎通过减少与食物剥夺相关的饥饿感来降低食物摄入量。相比之下,利莫那班不会改变对急性食物剥夺的辨别。使用食物剥夺辨别技术可能有助于确定特定神经活性化合物在饥饿感刺激进食中的作用,并可能有助于开发更有效的肥胖及其他饮食相关病症治疗药物。

相似文献

1
Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation.西布曲明和利莫那班对经训练可区分22小时和2小时食物剥夺的大鼠的影响。
Psychopharmacology (Berl). 2009 Apr;203(2):453-9. doi: 10.1007/s00213-008-1350-1. Epub 2008 Oct 15.
2
Comparison of rimonabant and sibutramine treatment effects on food compulsion in rats.利莫那班与西布曲明对大鼠强迫进食治疗效果的比较。
Acta Cir Bras. 2009 Nov-Dec;24(6):454-9. doi: 10.1590/s0102-86502009000600006.
3
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger.在经过训练以区分 22 小时和 2 小时禁食的大鼠中,阿片受体配体的作用表明阿片类物质在饥饿进食中没有参与。
Behav Brain Res. 2020 Feb 17;380:112369. doi: 10.1016/j.bbr.2019.112369. Epub 2019 Nov 17.
4
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.新型三重单胺再摄取抑制剂特斯司琼诱导饮食诱导肥胖大鼠持续减重和改善血糖控制:与西布曲明和利莫那班的比较。
Eur J Pharmacol. 2010 Jun 25;636(1-3):88-95. doi: 10.1016/j.ejphar.2010.03.026. Epub 2010 Apr 10.
5
Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats.暴露于预测食物供应的环境线索前会引发雌性大鼠下丘脑-垂体-肾上腺轴的激活,并增加其对食物的操作性反应。
Addict Biol. 2009 Sep;14(4):397-407. doi: 10.1111/j.1369-1600.2009.00152.x. Epub 2009 Apr 28.
6
[Pharmacological therapy of obesity].[肥胖症的药物治疗]
G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S.
7
5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.5-羟色胺(1A)激活可抵消西布曲明对大鼠的心血管作用,但不能抵消其食欲减退作用。
Obesity (Silver Spring). 2009 Mar;17(3):467-73. doi: 10.1038/oby.2008.550. Epub 2008 Dec 11.
8
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.大鼠对利莫那班抑制巧克力摄入量的作用缺乏耐受性。
Psychopharmacology (Berl). 2006 Apr;185(2):248-54. doi: 10.1007/s00213-006-0327-1. Epub 2006 Feb 21.
9
Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats.关于血清素受体亚型在西布曲明对大鼠不同进食模式影响中的作用的研究。
Br J Pharmacol. 1999 Jul;127(5):1190-4. doi: 10.1038/sj.bjp.0702633.
10
Regulation of body weight and carcass composition by sibutramine in rats.西布曲明对大鼠体重及胴体组成的调节作用
Obes Res. 2002 Mar;10(3):173-81. doi: 10.1038/oby.2002.27.

引用本文的文献

1
Hypothalamic control of interoceptive hunger.下丘脑对内脏饥饿感的控制。
Curr Biol. 2021 Sep 13;31(17):3797-3809.e5. doi: 10.1016/j.cub.2021.06.048. Epub 2021 Jul 16.
2
Effect of Oxytocin on Hunger Discrimination.催产素对饥饿辨别力的影响。
Front Endocrinol (Lausanne). 2019 May 15;10:297. doi: 10.3389/fendo.2019.00297. eCollection 2019.
3
A Prospective Evaluation of Drug Discrimination in Pharmacology.药理学中药物辨别力的前瞻性评估。

本文引用的文献

1
Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.在一项针对雌性大鼠的新型甜点实验方案中,大麻素1型受体拮抗剂通过减少对美味食物的选择来降低热量摄入。
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R67-75. doi: 10.1152/ajpregu.00150.2008. Epub 2008 Apr 30.
2
Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.大麻素CB1受体拮抗剂利莫那班对大鼠的辨别性刺激作用。
Psychopharmacology (Berl). 2008 Jul;198(4):467-78. doi: 10.1007/s00213-008-1076-0. Epub 2008 Feb 9.
3
The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food.
Curr Top Behav Neurosci. 2018;39:319-328. doi: 10.1007/7854_2018_59.
4
The rise (and fall?) of drug discrimination research.药物歧视研究的兴起(及衰落?)
Drug Alcohol Depend. 2015 Jun 1;151:284-8. doi: 10.1016/j.drugalcdep.2015.04.001.
5
Drug discrimination: 30 years of progress.药物辨别:30年的进展
Psychopharmacology (Berl). 2009 Apr;203(2):189-91. doi: 10.1007/s00213-009-1478-7. Epub 2009 Feb 19.
大麻素拮抗剂SR 141716A(利莫那班)可减少新型高适口性食物诱导的大鼠伏隔核细胞外多巴胺释放增加。
Neurosci Lett. 2007 Jun 4;419(3):231-5. doi: 10.1016/j.neulet.2007.04.012. Epub 2007 Apr 8.
4
Intraparaventricular neuropeptide Y and ghrelin induce learned behaviors that report food deprivation in rats.
Neuroreport. 2006 May 15;17(7):733-7. doi: 10.1097/01.wnr.0000215767.94528.fb.
5
Prevalence of overweight and obesity in the United States, 1999-2004.1999 - 2004年美国超重和肥胖的患病率
JAMA. 2006 Apr 5;295(13):1549-55. doi: 10.1001/jama.295.13.1549.
6
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.大麻素-1受体阻滞剂利莫那班对超重或肥胖患者体重及心血管代谢危险因素的影响:北美RIO研究:一项随机对照试验。
JAMA. 2006 Feb 15;295(7):761-75. doi: 10.1001/jama.295.7.761.
7
Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist.大麻素CB1受体拮抗剂SR-141716(利莫那班)对大鼠的辨别性刺激作用。
Psychopharmacology (Berl). 2004 Dec;177(1-2):35-45. doi: 10.1007/s00213-004-1916-5. Epub 2004 May 27.
8
The discovery and status of sibutramine as an anti-obesity drug.西布曲明作为一种抗肥胖药物的发现及现状。
Eur J Pharmacol. 2002 Apr 12;440(2-3):119-28. doi: 10.1016/s0014-2999(02)01423-1.
9
(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.(R)-甲烷酰胺和Δ9-四氢大麻酚作为大鼠的辨别性刺激物:大麻素拮抗剂SR-141716和内源性配体花生四烯乙醇胺的测试
Psychopharmacology (Berl). 2001 Aug;156(4):369-80. doi: 10.1007/s002130100730.
10
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance.西布曲明治疗肥胖症2年期间体重减轻及维持的预测因素。欧洲多中心STORM试验结果。西布曲明减肥及维持试验。
Int J Obes Relat Metab Disord. 2001 Apr;25(4):496-501. doi: 10.1038/sj.ijo.0801481.